Skip to search formSkip to main contentSkip to account menu

Advantan

Known as: Adventan, CSL brand of methylprednisolone aceponate, Schering brand of methylprednisolone aceponate 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

methylprednisolone aceponate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Стероидофобия в дерматологии - современная проблема из прошлого
Topical steroids are the first-line drugs for the treatment of the majority of dermatological diseases. Currently, however, often… 
2013
2013
Cotton-made cellulose support for anti-allergic pajamas.
2012
2012
Alleviation of a severe pruritic flare‐up in a 13‐year‐old child with chronic atopic dermatitis treated with methylprednisolone aceponate 0.1%
A 13‐year‐old girl with a 12‐year history of atopic dermatitis (AD), testing positive for inhalation and foodborne allergens… 
2012
2012
Methylprednisolone aceponate 0.1% in the treatment of pruritic lichenified eczema in a 3‐year‐old child with chronic atopic dermatitis
A 3‐year‐old girl with a > 2‐year history of atopic dermatitis (AD) and known egg allergy, presented with an extensive AD flare… 
2012
2012
Successful treatment of widespread eczema and sleep disruption in a 7‐month‐old infant with methylprednisolone aceponate 0.1%
A 7‐month‐old infant, with no known food allergy or intolerance, presenting with eczema lesions affecting many parts of his body… 
2008
2008
Advantan ®
The high lipophilicity of Advantan and the fact that it is bioactivated in the skin enables single daily application without any… 
1994
1994
Pharmacokinetics and ‘bioactivation’ of MPA
In order to display its pharmacological and therapeutic effects, a local corticosteroid has to be bioavailable at its target site… 
Review
1992
Review
1992
Methylprednisolone aceponate (MPA)* — a new therapeutic for eczema: A pharmacological overview
Advantan* is a new potent corticoid preparation that has been specially developed for the local treatment of eczematous… 
1992
1992
Safety aspects of topical methylprednisolone aceponate (MPA) treatment
Many side effects, both local or systemic, may result from topical steroid therapy, especially after long-lasting treatment with… 
1992
1992
Percutaneous absorption of methylprednisolone aceponate after single and multiple dermal application as ointment in male volunteers.
Six healthy, elderly volunteers were treated once daily with Advantan ointment containing 0.1% of methylprednisolone aceponate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)